2024-12-28 19:02:29
BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability Profile with BVX-1021
Corporate/ 2023-07-24
BioVaxys Sarbecovirus Vaccine Interim Da...

VANCOUVER,BC,Nov. 16,2022--BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)("BioVaxys" or "Company") is p...

Ascletis Announces IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors by China NMPA
Corporate/ 2023-07-24
Ascletis Announces IND Approval of Oral ...

--While the ASC61 Phase I study is ongoing in the U.S.,the Investigational New Drug (IND) approval in China will accelerate the global devel...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release